Zobrazeno 1 - 10
of 832
pro vyhledávání: '"Coats, AJS"'
Autor:
El Hadidi, S, Rosano, G, Tamargo, J, Agewall, S, Drexel, H, Kaski, JC, Niessner, A, Lewis, BS, Coats, AJS
Heart failure (HF) is a chronic debilitating and potentially life-threatening condition. HF patients are usually at high risk of polypharmacy and consequently, potentially inappropriate prescribing leading to poor clinical outcomes. Based on the publ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::f28fa3f4708dbec26d78717a288bd6b7
https://openaccess.sgul.ac.uk/id/eprint/112414/1/pvaa108.pdf
https://openaccess.sgul.ac.uk/id/eprint/112414/1/pvaa108.pdf
Autor:
Aimo, A, Vergaro, G, Gonzalez, A, Barison, A, Lupon, J, Delgado, V, Richards, AM, de Boer, RA, Thum, T, Arfsten, H, Hulsmann, M, Falcao-Pires, I, Diez, J, Foo, RSY, Chan, MYY, Anene-Nzelu, CG, Abdelhamid, M, Adamopoulos, S, Anker, SD, Belenkov, Y, Gal, TB, Cohen-Solal, A, Bohm, M, Chioncel, O, Jankowska, EA, Gustafsson, F, Hill, L, Jaarsma, T, Januzzi, JL, Jhund, P, Lopatin, Y, Lund, LH, Metra, M, Milicic, D, Moura, B, Mueller, C, Mullens, W, Nunez, J, Piepoli, MF, Rakisheva, A, Ristic, AD, Rossignol, P, Savarese, G, Tocchetti, CG, van Linthout, S, Volterrani, M, Seferovic, P, Rosano, G, Coats, AJS, Emdin, M, Bayes-Genis, A
Publikováno v:
European Journal of Heart Failure
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
In patients with heart failure, the beneficial effects of drug and device therapies counteract to some extent ongoing cardiac damage. According to the net balance between these two factors, cardiac geometry and function may improve (reverse remodelli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::08f694b65ad5047fcfb7f00f7343ac22
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7241
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7241
Autor:
Rosano, GMC, Seferovic, P, Savarese, G, Spoletini, I, Lopatin, Y, Gustafsson, F, Bayes-Genis, A, Jaarsma, T, Abdelhamid, M, Miqueo, AG, Piepoli, M, Tocchetti, CG, Ristic, AD, Jankowska, E, Moura, B, Hill, L, Filippatos, G, Metra, M, Milicic, D, Thum, T, Chioncel, O, Ben Gal, T, Lund, LH, Farmakis, D, Mullens, W, Adamopoulos, S, Bohm, M, Norhammar, A, Bollmann, A, Banerjee, A, Maggioni, AP, Voors, A, Solal, AC, Coats, AJS
Publikováno v:
ESC Heart Failure
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Heart failure (HF) is a long-term clinical syndrome, with increasing prevalence and considerable healthcare costs that are further expected to increase dramatically. Despite significant advances in therapy and prevention, mortality and morbidity rema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::705ec0e543aae4943eae118b13434dd5
http://hdl.handle.net/1942/37980
http://hdl.handle.net/1942/37980
Head-to-head comparison between recommendations by the ESC and ACC/AHA/HFSA heart failure guidelines
Autor:
Bayes-Genis, A, Aimo, A, Metra, M, Anker, S, Seferovic, P, Rapezzi, C, Castiglione, V, Nunez, J, Emdin, M, Rosano, G, Coats, AJS
Publikováno v:
European Journal of Heart Failure
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Recommendations represent the core messages of guidelines, and are particularly important when the body of scientific evidence is rapidly growing, as in the case of heart failure (HF). The main messages from two latest major HF guidelines, endorsed b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::455bcf9090108b35a5736d4c5a299a8a
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7112
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7112
Autor:
Bayes-Genis, A, Aimo, A, Jhund, P, Richards, M, De Boer, RA, Arfsten, H, Fabiani, I, Lupon, J, Anker, SD, Gonzalez, A, Castiglione, V, Metra, M, Mueller, C, Nunez, J, Rossignol, P, Barison, A, Butler, J, Teerlink, J, Filippatos, G, Ponikowski, P, Vergaro, G, Zannad, F, Seferovic, P, Rosano, G, Coats, AJS, Emdin, M, Januzzi, JL
Publikováno v:
European Journal of Heart Failure
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
The approval of new heart failure (HF) therapies has slowed over the past two decades in part due to the high costs of conducting large randomized clinical trials that are needed to adequately power major clinical endpoint studies. Several biomarkers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::efdea212d6dcc90f0ece90a1018e211f
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7303
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7303
Autor:
Gonzalez, A, Richards, AM, de Boer, RA, Thum, T, Arfsten, H, Hulsmann, M, Falcao-Pires, I, Diez, J, Foo, RSY, Chan, MY, Aimo, A, Anene-Nzelu, CG, Abdelhamid, M, Adamopoulos, S, Anker, SD, Belenkov, Y, Gal, TB, Cohen-Solal, A, Bohm, M, Chioncel, O, Delgado, V, Emdin, M, Jankowska, EA, Gustafsson, F, Hill, L, Jaarsma, T, Januzzi, JL, Jhund, PS, Lopatin, Y, Lund, LH, Metra, M, Milicic, D, Moura, B, Mueller, C, Mullens, W, Nunez, J, Piepoli, MF, Rakisheva, A, Ristic, AD, Rossignol, P, Savarese, G, Tocchetti, CG, Van Linthout, S, Volterrani, M, Seferovic, P, Rosano, G, Coats, AJS, Bayes-Genis, A
Publikováno v:
European Journal of Heart Failure
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Cardiac remodelling refers to changes in left ventricular structure and function over time, with a progressive deterioration that may lead to heart failure (HF) development (adverse remodelling) or vice versa a recovery (reverse remodelling) in respo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::500c8bad34f23001b68044655270d4ef
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7196
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7196
Autor:
McEwan, P, Ponikowski, P, Davis, JA, Rosano, G, Coats, AJS, Dorigotti, F, O'Sullivan, D, Ramirez de Arellano, A, Jankowska, EA
AIMS: Iron deficiency is common in patients with heart failure (HF). In AFFIRM-AHF, ferric carboxymaltose (FCM) reduced the risk of hospitalisations for HF (HHF) and improved quality of life vs. placebo in iron-deficient patients with a recent episod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::b5b99d940be4a2383efb91ce5e8d15dd
https://openaccess.sgul.ac.uk/id/eprint/113494/1/ejhf.2270.pdf
https://openaccess.sgul.ac.uk/id/eprint/113494/1/ejhf.2270.pdf
Autor:
Seferović, PM, Fragasso, G, Petrie, M, Mullens, W, Ferrari, R, Thum, T, Bauersachs, J, Anker, SD, Ray, R, Çavuşoğlu, Y, Polovina, M, Metra, M, Ambrosio, G, Prasad, K, Seferović, J, Jhund, PS, Dattilo, G, Čelutkiene, J, Piepoli, M, Moura, B, Chioncel, O, Gal, TB, Heymans, S, De Boer, RA, Jaarsma, T, Hill, L, Lopatin, Y, Lyon, AR, Ponikowski, P, Lainščak, M, Jankowska, E, Mueller, C, Cosentino, F, Lund, L, Filippatos, GS, Ruschitzka, F, Coats, AJS, Rosano, GMC
Heart failure (HF) is common and associated with a poor prognosis, despite advances in treatment. Over the last decade cardiovascular outcome trials with sodium–glucose co‐transporter 2 (SGLT2) inhibitors in patients with type 2 diabetes mellitus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::cb09618348b16803a116d10be2eccc78
https://openaccess.sgul.ac.uk/id/eprint/112153/1/ejhf.1954.pdf
https://openaccess.sgul.ac.uk/id/eprint/112153/1/ejhf.1954.pdf
Autor:
Kapelios, CJ, Laroche, C, Crespo-Leiro, MG, Anker, SD, Coats, AJS, Díaz-Molina, B, Filippatos, G, Lainscak, M, Maggioni, AP, McDonagh, T, Mebazaa, A, Metra, M, Moura, B, Mullens, W, Piepoli, MF, Rosano, GMC, Ruschitzka, F, Seferovic, PM, Lund, LH, Heart Failure Long-Term Registry Investigators Group
AIMS: Guidelines recommend down-titration of loop diuretics (LD) once euvolaemia is achieved. In outpatients with heart failure (HF), we investigated LD dose changes in daily cardiology practice, agreement with guideline recommendations, predictors o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::ac913b99e483c4c6247de6a858852343
https://openaccess.sgul.ac.uk/id/eprint/111908/1/CrespoLeiro_Maria_2020_Association_between_loop_diuretic_dose_changes.pdf
https://openaccess.sgul.ac.uk/id/eprint/111908/1/CrespoLeiro_Maria_2020_Association_between_loop_diuretic_dose_changes.pdf
Benefits and safety on statins have been well-established over 20 years of research. Despite this, the vast majority of patients are not adequately treated and do not achieve the low-density lipoprotein cholesterol target levels. This is mainly due t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::aafb8181694d477c3c06bba324b74510
https://openaccess.sgul.ac.uk/id/eprint/111911/1/DrexelH_ESCPositionPaperonStatinAdherence_EurHeartJCardioPharm_2019.pdf
https://openaccess.sgul.ac.uk/id/eprint/111911/1/DrexelH_ESCPositionPaperonStatinAdherence_EurHeartJCardioPharm_2019.pdf